Clinical Trial Update: Safety, Tolerability and Pharmacokinetics Study of CK-3773274 [Phase 1]

View source ↗

Summary

Completed Phase 1 safety, tolerability, and pharmacokinetics evaluation of CK-3773274, including subjects with obstructive hypertrophic cardiomyopathy and healt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Hypertrophic Cardiomyopathy

Drugs mentioned

• CK-3773274

Snippet

Sponsor: Corxel Pharmaceuticals | Conditions: Obstructive Hypertrophic Cardiomyopathy, Healthy Adult Subjects | Phase 1 | Status: COMPLETED